Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the treatment of systemic lupus erythematosus

US Patent 11660302 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Machine-learning system and method for identifying same person in genealogical d2025
Leak electricity protective breaker2025
Residual current monitoring and protection module2025
Five-membered ring-fused six-membered ring compound, preparation method therefor2025
Five-membered-fused six-membered compound, preparation method, pharmaceutical co2025
Cat climbing frame2025
Cat climbing frame2025
Conveniently-mounted split side-emitting small panel lamp2025
Five- and six-membered compound, and preparation method therefor and pharmaceuti2025
Methods for treating systemic lupus erythematosus and the use of biomarkers as a2024
Agomelatine oral transmucosal film2024
Therapeutic antibodies and their uses2023